A study in healthy male subjects to understand how savolitinib when taken with midazolam behaves inside the body

Trial Identifier:	D5084C00004
Sponsor:	AstraZeneca
Collaborator:	Parexel
NCTID::	NCT04187456
Start Date:	December 2019
Primary Completion Date:	March 2020
Study Completion Date:	March 2020
Condition:	Cancer - Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language	Description
	English version

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
United States of America, MD	Baltimore, MD, United States of America, 21225

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.